Canopy Growth (TSX: CGC), specializing in the production of marijuana, has gone parabolic.
Today, 12.9 million shares traded (about 10% of the company) around a level that valued the entire entity at around CAD$1.5 billion.
Fundamentally, looking at their last quarterly report, they have sold $15 million of marijuana in the last 6 months.
If you (exponentially) extrapolate their revenue growth curve, they will be selling over $1 billion in marijuana in five years.
Somehow, I don’t think this will happen.
I am predicting two things:
1. Management is going to do a massive secondary offering. They did two of them earlier in 2016 (raising an 8-digit sum of money), but they will scramble to raise an even bigger amount of money which would pay for a lot of marketing. I’m guessing they’re going to aim for over a hundred million. I’d do the same if I were in their shoes, in addition to personally selling shares at the earliest possible opportunity.
2. Eventually, within the next six months, a lot of people are going to lose money on this stock.
Right now, if you are short, I can imagine the pain. Maybe those short on the stock should get a prescription of medical marijuana to ease the pain.
No positions, no intention to take any, but looking at this stock with amusement.
Not shockingly, there is ZERO borrow at Interactive Brokers, and if you were lucky enough to get it, the short lease rate is over 50-freaking percent!
No trading options either. Sigh…
Huge fan of the product….but not the stock.
[…] Divestor wrote about the insanity surrounding Canopy Growth Corp, the largest marijuana stock. I also warned about investing in the marijuana […]
They raised $60 million in a bought deal, but also used their stock as currency for a couple large acquisitions. Good for them, striking the iron while it is still hot. So many people are going to lose money on this.